Stockreport

Nanobiotix to Participate in Multiple Investor Conferences in February and March 2025

Nanobiotix S.A. - ADSs  (NBTX) 
PDF PARIS and CAMBRIDGE, Mass., Jan. 29, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology compan [Read more]